In a study that could lead to new benign targets for craft with the cystic fibrosis, a inquiry team from the health center of California, San Diego School of vaccine has identified a defective signaling pathway that contributes to disease severity. In the study, published in the journal Nature Medicine, the researchers report that defective signaling for a protein called the peroxisome proliferator-activated receptor-γ (PPAR-γ) inside for a portion of disease ailment in cystic fibrosis, and that correction of the defective pathway reduces disturb of the disease in mice...

More: - Read More